SR

Suchritha Reddy Patlolla

Active Director Director DIN 11354428
DIN 11354428 First appointment Jan 2026 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since Jan 2026
Shareholding value - Across - companies

About Suchritha Reddy Patlolla

Suchritha Reddy Patlolla has experience in corporate governance. Holds Director role. Currently with 1 company, including Airis Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 11354428
Primary Designation Director
First Appointment 05 Jan 2026
Oldest Company Age Not Provided

Current companies

Company Designation Appointment Founded Status
Airis Pharma Private Limited U24232TG2013PTC089550
Director 05 Jan 2026 Not Provided Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Airis Pharma Private Limited

Shareholding

Pro
Shareholding preview is available in the premium director profile.

Shares held, value and quarterly changes across all companies — with the full investment profile.

Unlock shareholding

Frequently Asked Questions about Suchritha Reddy Patlolla

Suchritha Reddy Patlolla has experience in corporate governance. Holds Director role. Currently with 1 company, including Airis Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

Suchritha Reddy Patlolla is associated with 1 company as Director.

Suchritha Reddy Patlolla has expertise in General Business.

Suchritha Reddy Patlolla has extensive experience in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available